Label: ALTACHLORE SODIUM CHLORIDE HYPERTONICITY OPHTHALMIC 5 PERCENT- sodium chloride ointment
- NDC Code(s): 59390-184-50
- Packager: Altaire Pharmaceuticals Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated March 18, 2026
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient
- Purpose
- Use
-
Warnings
• For use in the eyes only.
• Retain carton for full product drug facts.
When using this product
• avoid contamination, do not touch tip of container to any surface.
• replace cap after each use.
• this product may cause temporary burning and irritation on being instilled into the eye.
- Directions
- Other information
- Inactive ingredients
- Questions or comments?
-
PRINCIPAL DISPLAY PANEL
Compare to the active ingredient in MURO128®*
ISolutions™
Activeyes®
ALTACHLORE
Sodium Chloride
Hypertonicity
Ophthalmic
Ointment 5%
•FOR TEMPORARY RELIEF OF CORNEAL EDEMA
Sterile
NET WT 3.5g (1/8 OZ)*This product is not manufactured or distributed by Bausch & Lomb, Inc., owner of the registered trademark MURO128®

-
INGREDIENTS AND APPEARANCE
ALTACHLORE SODIUM CHLORIDE HYPERTONICITY OPHTHALMIC 5 PERCENT
sodium chloride ointmentProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:59390-184 Route of Administration OPHTHALMIC Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Sodium Chloride (UNII: 451W47IQ8X) (Sodium Cation - UNII:LYR4M0NH37) Sodium Chloride 50 mg in 1 g Inactive Ingredients Ingredient Name Strength LANOLIN ALCOHOL (UNII: 884C3FA9HE) MINERAL OIL (UNII: T5L8T28FGP) WATER (UNII: 059QF0KO0R) WHITE PETROLATUM (UNII: B6E5W8RQJ4) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:59390-184-50 1 in 1 BOX 03/30/2004 1 3.5 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M018 03/30/2004 Labeler - Altaire Pharmaceuticals Inc. (786790378)
